DiNAQOR is a genetic medicine platform company pioneering early-stage drug development and manufacturing to advance promising gene therapies to the clinic. Our patent-protected, industry leading platform is designed to overcome the challenges and limitations of advanced gene therapy development by using proprietary engineered heart tissue technology (EHT), a novel Loco-Regional Perfusion system (LRP) and a fully integrated manufacturing solution. Our company is headquartered in the Greater Zurich Area, Switzerland, with additional presence in Laguna Hills, California and Hamburg, Germany.
| Website | http://www.dinaqor.com/ |
| Employees | 9 (9 on RocketReach) |
| Founded | 2019 |
| Address | Wagistrasse 25, Schlieren, Zurich 8952, CH |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Clinical Stage, Gene Therapy, Platform Technology, Genetic Medicine, Drug Development, Pharmaceutical Manufacturing, Biotechnology, Clinical Trials, Precision Medicine, Dna Sequencing, Gene Editing, Cell Therapy, Oncology, Rare Diseases, Molecular Medicine, Drug Discovery, Biopharma, Therapeutics, Pharmaceutical Research, Life Sciences |
| Competitors | Roche, Novartis, AbbVie, Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences +49 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular DiNAQOR employee's phone or email?
Johannes Holzmeister is the Chairman and CEO of DiNAQOR.
9 people are employed at DiNAQOR.
DiNAQOR is based in Schlieren, Zurich.
The NAICS codes for DiNAQOR are [325, 3254, 32].
The SIC codes for DiNAQOR are [80, 283, 28].